Enhancement of fibrinolytic activity of human plasma in the presence of acetone

References

• Nilsson T K, Wallen P B. The fibrinolytic system: biochemistry and assay methods. Clinical Aspects of Fibrinolysis, T K Nilsson, K Boman, J H Jansson. Almquist and Wiksell International, Stockholm 1991
   Google Scholar
• Collen D. On the regulation and control of fibrinolysis. Thromb Haemost 1980; 43: 77–89
   PubMed Web of Science ®Google Scholar
• Marsh N. Fibrinolysis. John Wiley and Sons, Chichester 1981
   Google Scholar
• Kluft C, Wijngaards G, Jie A HF. Intrinsic plasma fibrinolysis. Involvement of urokinase-related activity in the factor XII independent plasminogen proactivator pathway. J Lab Clin Med 1984; 103: 408–19
   Google Scholar
• Adamus K, Pajdak W. Amidolytic activities in acetone-treated human plasma. Folia Histochem Cytobiol 1992; 30: 219–22
   Google Scholar
• Hoem N O, Briseid K. Activation of factor XII in acetone treated human plasma. Significance of the functional state of plasma kallikrein for the extent of activation. Acta Pharmacol Toxicol 1986; 58: 144–50
   Google Scholar
• Hoem N O, Johannesen S, Briseid K. Formation of an association between factor XII and kallikrein in human plasma-significance of storage of plasma and the functional state of plasma kallikrein. Thromb Res 1992; 66: 421–34
   Google Scholar
• Nilsson T K. Analysis of factors affecting tissue plasminogen activator activity and antigen concentration before and after venous occlusion in 123 patients. Clin Chem Enzymol Comms 1989; 1: 335–41
   Google Scholar
• Melnick P J. Pathology of leukemia, G D Amromin. Harper and Row Inc., New York 1960
   Google Scholar
• Pajdak W, Lisiewicz J. Heterogenity of enzymes in leukemic eosinophils. Scand J Haemat 1973; 11: 325–33
   Google Scholar
• Clarke J T. Simplified “disc” polyacrylamide gel electrophoresis. Ann NY Acad Sci 1964; 121: 428–36
   PubMed Web of Science ®Google Scholar
• Weeke B. Crossed Immunoelectrophoresis. Scand J Immunol 1973; 2(suppl. 1)47–56
   Web of Science ®Google Scholar
• Ditzel J. Effect of plasma inorganic phosphate on tissue oxygenation during recovery from diabetic ketoacidosis. Adv Exp Med Biol 1973; 37A: 163–9
   PubMedGoogle Scholar
• French R M. Guide to diagnostic procedures, L A Dysart, R J Leap, J J Fitzpatrick. McGraw-Hill Book Company. 1980
   Google Scholar
• Philo R D, Gaffney P J. Some observation on the assay of plasminogen using streptokinase and S-2251. Haemostasis 1982; 11(suppl. 1)66
   Google Scholar
• Chmielewska J, Ranby M, Wiman B. Kinetics of the inhibition of plasminogen activators by the plasminogen activator inhibitors. Biochem J 1988; 251: 327–32
   PubMedGoogle Scholar
• Gallimore M J, Friberger P. Simple chromogenic peptide substrate assays for determining prekalli-krein, kallikrein like activity in human plasma. Thromb Res 1982; 25: 293–8
   PubMed Web of Science ®Google Scholar
• Vinazzer H. Assay of total factor XII and of activated factor XII in plasma with a chromogenic substrate. Thromb Res 1974; 14: 155–66
   Google Scholar
• Verstraete M, Vermylen J. Thrombosis. Pergamon Press, Oxford 1984
   Google Scholar
• Nilsson T, Back O. Elevated plasmin-alpha 2-anti-plasmin complex levels in hereditary angioedema, evidence for the intrinsic fibrinolytic system. Thromb Res 1985; 40: 817–21
   PubMed Web of Science ®Google Scholar
• Kok P, Nilsson T. Assay characteristics and fibrin affinity of plasminogen activators of the intrinsic fibrinolytic system. Thromb Res 1986; 41: 197–209
   PubMed Web of Science ®Google Scholar
• Wallen P. Degradation of fibrinogen. Scand J Haematol 1971, suppl. 13: 3–14
   Google Scholar
• Astrup T. Fibrinolysis: an overview, J F Davidson, R M Rowan, M M Samama, R C Desnoyers. Raven Press, New York 1978
   Google Scholar
• Kaplan A P, Silverberg M. The coagulation-kinin pathway of human plasma. Blood 1987; 70: 1–15
   PubMed Web of Science ®Google Scholar
• Blomback B. Fibrinogen and fibrin. Structure, biosynthesis, interactions and roles in fibrinolysis, J Goldstein. Butterworths, New York 1992
   Google Scholar
• Svenson E, Lutzen O, Thorsen S. Initial plasmin degradation of fibrin as the basis of a positive feed-back mechanism in fibrinolysis. Eur J Bio-chem 1984; 140: 513–22
   Google Scholar
• Sharma S C. Platelet adhesiveness, plasma fibrinogen and fibrinolytic activity in juvenile-onset and maturity-onset diabetes mellitus. J Clin Pathol 1981; 34: 501–5
   Google Scholar
• Ostemann H, Tschope D, Greber W, Meyer-Rusenberg H W, van de Loo J. Enhancement of spontaneous fibrinolytic activity in diabetic retinopathy. Thromb Haemostas 1992; 88: 400–3
   Google Scholar
• Christe M, Fritschi J, Lammle B, et al. Fifteen coagulation and fibrinolysis parameters in diabetes mellitus and in patients with vasculopathy. Thromb Haemostas 1984; 52: 138–42
   Google Scholar
• Fuller J H, Keen H, Jarrett R J, et al. Haemostatic variables associated with diabetes and its complications. BMJ 1979; 11: 964–6
   Google Scholar
• Knaap J H, de Boer A C, Pannebakker M AG, van Heerde W, den Ottolander G JH. The effect of diabetes regulation on platelet release, fibrinolysis and coagulation tests, before and after stimulation with DDAVP. Thromb Haemostas 1985; 53: 118–21
   Google Scholar